Iradimed (IRMD) Free Cash Flow Growth (1y) (2014 - 2026)
Iradimed (IRMD) Free Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | -109.40% |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 363.84% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -31.71% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn | 133.09% |
| 10 | Iradimed | 1.21 Bn | 1.16 Bn | 16.81 Mn | 1,225.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,225.55% |
| Dec 31, 2025 | 76.08% |
| Sep 30, 2025 | 10.23% |
| Jun 30, 2025 | -6.10% |
| Mar 31, 2025 | -83.81% |
| Dec 31, 2024 | -68.83% |
| Sep 30, 2024 | 389.19% |
| Jun 30, 2024 | 286.01% |
| Mar 31, 2024 | -18.06% |
| Dec 31, 2023 | 268.77% |
| Sep 30, 2023 | -71.04% |
| Jun 30, 2023 | -301.68% |
| Mar 31, 2023 | 260.87% |
| Dec 31, 2022 | -20.50% |
| Sep 30, 2022 | 21.31% |
| Jun 30, 2022 | -58.69% |
| Mar 31, 2022 | 37.87% |
| Dec 31, 2021 | 31.92% |
| Sep 30, 2021 | 178.79% |
| Jun 30, 2021 | 320.76% |